Company: UPC
Filing Date: 2025-07-29
Form Type: 6-K
Source: 0001213900-25-068704
Chunk: 0

Company: Universe Pharmaceuticals INC
Filing Date: 2025-07-29
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2025

Commission file number: 001-40231

Universe Pharmaceuticals INC

265 Jingjiu Avenue
Jinggangshan Economic and Technological Development Zone
Ji’an, Jiangxi, China 343100
+86-0796-8403309
(Address of principal executive offices)</div>

Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒ Form 40-F
☐</div>

In connection with the 2025 Annual General Meeting
of Shareholders of Universe Pharmaceuticals INC, an exempted company incorporated under the laws of the Cayman Islands (the “Company”),
the Company hereby furnishes the following documents:

Exhibits

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

| Date: July 29, 2025 | Universe Pharmaceuticals INC. 
 By:                           | /s/ Gang Lai            |
|:--------------------|:------------------------------|:------------------------|
|                     |                               | Gang Lai                |
|                     |                               | Chief Executive Officer |

<div align='center'>2</div>